NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma

Figure 3

Evaluation of NUDT1 expression on survival of patients with ccRCC: (a) Kaplan–Meier analysis of overall survival based on NUDT1 expression; (b) Kaplan–Meier analysis of progression-free survival based on NUDT1 expression; (c) the areas under the ROC curve about 1, 3, and 5 years.

(a)

(b)

(c)